Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | PORCN | Q9H237 | 2/20 | 0.55 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 6/20 | 0.52 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1013306 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL29644534 | 0.98 | ALDH1A1 (0.59) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL31090358 | 0.98 | ALDH1A1 (0.59) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL29021371 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL24757867 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL20380072 | 0.84 | NAMPT (0.56) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL896314 | 0.83 | KCNQ3 (0.64) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL590618 | 0.82 | KMT2A (0.61) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL1010493 | 0.82 | ALDH1A1 (0.56) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL31728525 | 0.82 | ALDH1A1 (0.56) | ALDH1A1MAPTMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970123-B2 | CRYSTALLINE DIHYDROCHLORIDE HYDRATE SALT OF OMECAMTIV MECARBIL AND PROCESS FOR ITS PREPARATION | AMGEN INC (US) | 2025-12-10 | — | — | EP | claimed |
| US-11958809-B2 | Salt of omecamtiv mecarbil and process for preparing salt | CYTOKINETICS, INC. (US) | 2024-04-16 | — | — | US | claimed |
| US-20220153700-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | CYTOKINETICS, INC. | 2022-05-19 | — | — | US | claimed |
| US-12583821-B2 | Salt of omecamtiv mecarbil and process for preparing salt | CYTOKINETICS, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| EP-2970123-B2 | CRYSTALLINE DIHYDROCHLORIDE HYDRATE SALT OF OMECAMTIV MECARBIL AND PROCESS FOR ITS PREPARATION | AMGEN INC (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250243163-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | AMGEN INC. | 2025-07-31 | — | — | US | disclosed |
| US-12221417-B2 | Salt of omecamtiv mecarbil and process for preparing salt | CYTOKINETICS, INC. (US) | 2025-02-11 | — | — | US | disclosed |
| US-20240317687-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | CYTOKINETICS, INC. | 2024-09-26 | — | — | US | disclosed |
| US-11958809-B2 | Salt of omecamtiv mecarbil and process for preparing salt | CYTOKINETICS, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240101517-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | AMGEN INC. | 2024-03-28 | — | — | US | disclosed |
| US-20230044617-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | CYTOKINETICS, INC. | 2023-02-09 | — | — | US | disclosed |
| US-11472773-B2 | Salt of omecamtiv mecarbil and process for preparing salt | CYTOKINETICS, INC. (US) | 2022-10-18 | — | — | US | disclosed |
| US-20220153700-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | CYTOKINETICS, INC. | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230044617-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-20250243163-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-20220153700-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-20240317687-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-11472773-B2 | Salt of omecamtiv mecarbil and process for preparing salt | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-20240101517-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-12583821-B2 | Salt of omecamtiv mecarbil and process for preparing salt | SLC28A2, SLC28A1, SLC5A11 | ALDH1A1 1521/4885MAPT 1853/4885MEN1 252/4885 |
| US-11958809-B2 | Salt of omecamtiv mecarbil and process for preparing salt | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
| US-12221417-B2 | Salt of omecamtiv mecarbil and process for preparing salt | SI, SLC5A6, SLC28A1 | ALDH1A1 1835/4885MAPT 2385/4885MEN1 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.